U.S. Supreme Court Finds Against Amgen: The More You Claim the More You Must Enable; The Result of Being too Obscure, Loose, and Imperfect Court CasesCourt DecisionsMichelle E. O’BrienPatentThomas L. Irving U.S. Supreme Court Finds Against Amgen: The More You Claim the More You Must Enable; The Result of Being too Obscure, Loose, and Imperfect
U.S. Supreme Court Denies Teva’s Petition for Certiorari in Skinny Label Case Court DecisionsMichelle E. O’BrienThomas L. Irving U.S. Supreme Court Denies Teva’s Petition for Certiorari in Skinny Label Case
USPTO Issues Advance Notice of Proposed Rulemaking: Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings before the Patent Trial and Appeal PTAB Court CasesMichelle E. O’BrienPatentRobert M. HansenThomas L. Irving USPTO Issues Advance Notice of Proposed Rulemaking: Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings before the Patent Trial and Appeal PTAB
Patenting Polymorphs: Opportunities and Challenges, discussing all aspects of patenting polymorphs from drafting through patent prosecution and enforcement Firm NewsMichelle E. O’BrienThomas L. Irving Patenting Polymorphs: Opportunities and Challenges, discussing all aspects of patenting polymorphs from drafting through patent prosecution and enforcement
Drafting and Prosecuting Patent Applications to Survive a Markman Hearing: Claim Construction Case Studies Firm NewsMichelle E. O’Brien Drafting and Prosecuting Patent Applications to Survive a Markman Hearing: Claim Construction Case Studies
Doctrine of Equivalents in Patent Prosecution: DOE Application, Festo Exceptions, Recent Case Law Developments Webinar Firm NewsMichelle E. O’Brien Doctrine of Equivalents in Patent Prosecution: DOE Application, Festo Exceptions, Recent Case Law Developments Webinar
Sunday, September 18th, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” discussion Firm NewsMichelle E. O’Brien Sunday, September 18th, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” discussion
Thursday, August 4, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” Firm NewsMichelle E. O’Brien Thursday, August 4, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case”
Kansas State Bar Association’s 2022 Intellectual Property Institute “Patent Year in Review” – Friday June 3, 2022 Firm NewsMichelle E. O’Brien Kansas State Bar Association’s 2022 Intellectual Property Institute “Patent Year in Review” – Friday June 3, 2022
Friday, May 20, 2022 – Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp Firm NewsMichelle E. O’Brien Friday, May 20, 2022 – Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp